Interestingly, Brastianos et al. identified an activating CTNNB1 mutation in a brain metastasis of a HER2+ breast cancer patient, which was also not detectable in the primary tumor or the other two brain metastasis samples40. Here, ERBB2 is linked to breast carcinoma.